Cargando…

Developments in the Role of Endothelin-1 in Atherosclerosis: A Potential Therapeutic Target?

Detalles Bibliográficos
Autores principales:	Sutton, Greg, Pugh, Dan, Dhaun, Neeraj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694011/ https://www.ncbi.nlm.nih.gov/pubmed/31145445 http://dx.doi.org/10.1093/ajh/hpz091

Ejemplares similares

Endothelin
por: Davenport, Anthony P., et al.
Publicado: (2016)

Comment on: A novel model to assess disease activity in Takayasu arteritis based on (18)F-FDG PET/CT: a Chinese cohort study
por: Pugh, Dan, et al.
Publicado: (2021)

Pulse-wave velocity is associated with cognitive impairment in haemodialysis patients
por: Miller-Hodges, Eve, et al.
Publicado: (2017)

Plasma Pro‐Endothelin‐1 Peptide Concentrations Rise in Chronic Kidney Disease and Following Selective Endothelin A Receptor Antagonism
por: Dhaun, Neeraj, et al.
Publicado: (2015)

MD-2 as a possible therapeutic target for atherosclerosis
por: Chen, Shuang, et al.
Publicado: (2020)

The modifiers of chronic kidney disease in autosomal dominant polycystic kidney disease and the role of the endothelin-1
por: Einollahi, Behzad, et al.
Publicado: (2016)

Management of Hypertension in Chronic Kidney Disease
por: Pugh, Dan, et al.
Publicado: (2019)

Correction to: Management of Hypertension in Chronic Kidney Disease
por: Pugh, Dan, et al.
Publicado: (2020)

A novel role for myeloid endothelin-B receptors in hypertension
por: Czopek, Alicja, et al.
Publicado: (2019)

Renin‐Angiotensin and Endothelin Systems in Patients Post‐Takotsubo Cardiomyopathy
por: Khan, Hilal, et al.
Publicado: (2022)

The role of statins as potential targets for bone formation
por: Garrett, I Ross, et al.
Publicado: (2002)

Investigating the specificity of endothelin-traps as a potential therapeutic tool for endothelin-1 related disorders
por: Jain, Arjun, et al.
Publicado: (2022)

Endothelin antagonists in subarachnoid hemorrhage: what next?
por: Macdonald, R Loch
Publicado: (2012)

Sunitinib-induced cardiac hypertrophy and the endothelin axis
por: Sourdon, Joevin, et al.
Publicado: (2021)

The Endothelin Type A Receptor as a Potential Therapeutic Target in Preeclampsia
por: Bakrania, Bhavisha, et al.
Publicado: (2017)

Endothelin antagonists: new bullets against lung injury?
por: Leeman, Marc
Publicado: (2005)

The dawn has come for new therapeutics to treat atherosclerosis: Targeting neuroimmune cardiovascular interfaces in artery brain circuits
por: Mohanta, Sarajo Kumar, et al.
Publicado: (2022)

Clues to Glomerular Cell Chatter in Focal Segmental Glomerulosclerosis: Via Endothelin-1/ET(A)R
por: Lassén, Emelie, et al.
Publicado: (2021)

Cardiac Metabolic Deregulation Induced by the Tyrosine Kinase Receptor Inhibitor Sunitinib is rescued by Endothelin Receptor Antagonism
por: Sourdon, Joevin, et al.
Publicado: (2017)

Monitoring Endothelin-A Receptor Expression during the Progression of Atherosclerosis
por: Stölting, Miriam, et al.
Publicado: (2020)

The Role of Endothelin-1 and Endothelin Receptor Antagonists in Inflammatory Response and Sepsis
por: Kowalczyk, Agata, et al.
Publicado: (2014)

The therapeutic potential of apelin in kidney disease
por: Chapman, Fiona A., et al.
Publicado: (2021)

Serial troponin measurements to monitor risk and response to endothelin A antagonism in chronic kidney disease
por: Anand, Atul, et al.
Publicado: (2020)

Thrombospondin1 as a potential therapeutic target for human nonalcoholic fatty liver disease
por: Song, Yongfeng, et al.
Publicado: (2020)

Orai1 as a potential “fits-all approach” therapeutic target for the treatment of DMD
por: Cheng, Arthur J., et al.
Publicado: (2023)

Endothelin-1 Mediates the Systemic and Renal Hemodynamic Effects of GPR81 Activation
por: Jones, Natalie K., et al.
Publicado: (2020)

The potential role of nanomedicine on COVID-19 therapeutics
por: Mainardes, Rubiana Mara, et al.
Publicado: (2020)

Targeting Endothelin in Alzheimer's Disease: A Promising Therapeutic Approach
por: Sharma, Shiwali, et al.
Publicado: (2021)

Role of TRIB3 in Diabetic and Overnutrition-Induced Atherosclerosis
por: Sowers, James R.
Publicado: (2012)

Potential therapeutic targets for atherosclerosis in sphingolipid metabolism
por: Yu, Zemou, et al.
Publicado: (2019)

Targeting the endothelin axis as a therapeutic strategy for oral cancer metastasis and pain
por: Dang, Dongmin, et al.
Publicado: (2020)

Transgelin in bladder cancer: A potential biomarker and therapeutic target
por: Li, Wei-Ming, et al.
Publicado: (2019)

Bilirubin: A Potential Biomarker and Therapeutic Target for Diabetic Nephropathy
por: Hull, Travis D., et al.
Publicado: (2014)

Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia
por: Davidson, Michael H.
Publicado: (2015)

Cyclophosphamide-Induced Lung Injury
por: Pugh, Dan, et al.
Publicado: (2018)

The role of advanced MRI in the development of treat-to-target therapeutic strategies, patient stratification and phenotyping in rheumatoid arthritis
por: Mobasheri, Ali, et al.
Publicado: (2020)

Role of Endoplasmic Reticulum Stress in Atherosclerosis and Its Potential as a Therapeutic Target
por: Yang, Shengjie, et al.
Publicado: (2020)

First-in-Man Demonstration of Direct Endothelin-Mediated Natriuresis and Diuresis
por: Hunter, Robert W., et al.
Publicado: (2017)

αTAT1: a potential therapeutic target in cancer?
por: Chien, J-Y, et al.
Publicado: (2016)

Identifying genes that regulate bone remodeling as potential therapeutic targets
por: Krane, Stephen M.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_a9j56t4darl6khpskd665egnmv